Preparation of Paeonol-HP-β-cyclodextrin Inclusion Compound and Its Prescription Technology Optimiza-tion
10.6039/j.issn.1001-0408.2017.04.27
- VernacularTitle:丹皮酚-羟丙基-β-环糊精包合物的制备及处方工艺优化
- Author:
Xin ZHENG
;
Peihong YANG
;
Lin HE
;
Xi CHEN
;
Mo CHENG
;
Bibo YOU
- Keywords:
Paeonol;
HP-β-CD;
Inclusion compound;
Central composite design-response surface methodology;
Prescription technology;
Optimization
- From:
China Pharmacy
2017;28(4):530-532,533
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To prepare paeonol-HP-β-cyclodextrin (PAE-HP-β-CD) inclusion compound and to optimize its pre-scription technology. METHODS:PAE-HP-β-CD was prepared by freeze drying method and validated. Using inclusion rate as in-dex,main drug-accessory ratio,inclusion time,inclusion temperature and stirring speed as factors,the preparation technology was optimized by central composite design-response surface methodology. RESULTS:Prepared PAE-HP-β-CD underwent phase transfor-mation. The optimal inclusion technology was as follows as main drug-accessory ratio of 3.39∶1,inclusion temperature of 50 ℃, inclusion time of 3.2 h, stirring speed of 350 r/min. Relative error between measured value (87.46%) and predicted value (89.12%) of inclusion rate was 1.86%(n=6). CONCLUSIONS:PAE-HP-β-CD inclusion compound is prepared successfully, and its prescription technology is stable and feasible.